3.5 USD
-0.02 (-0.57%)
3.49 USD
-0.01 (-0.29%)
Overall LFMD gets a fundamental rating of 3 out of 10. We evaluated LFMD against 34 industry peers in the Health Care Technology industry. LFMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, LFMD is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- LFMD had negative earnings in the past year.
- LFMD had a positive operating cash flow in the past year.
- In the past 5 years LFMD always reported negative net income.
- The reported operating cash flow has been mixed in the past 5 years: LFMD reported negative operating cash flow in multiple years.
1.2 Ratios
- LFMD's Return On Assets of -11.68% is in line compared to the rest of the industry. LFMD outperforms 55.88% of its industry peers.
- LFMD has a worse Return On Equity (-586.53%) than 85.29% of its industry peers.
- With an excellent Return On Invested Capital value of 5.81%, LFMD belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROIC | 5.81% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- LFMD has a Operating Margin of 0.27%. This is in the better half of the industry: LFMD outperforms 61.76% of its industry peers.
- LFMD has a better Gross Margin (86.96%) than 91.18% of its industry peers.
- In the last couple of years the Gross Margin of LFMD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFMD is destroying value.
- LFMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, LFMD has more shares outstanding
- Compared to 1 year ago, LFMD has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -0.11, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
- LFMD has a Altman-Z score (-0.11) which is comparable to the rest of the industry.
- LFMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -0.11 |
ROIC/WACC0.58
WACC9.97%
2.3 Liquidity
- A Current Ratio of 0.73 indicates that LFMD may have some problems paying its short term obligations.
- The Current ratio of LFMD (0.73) is worse than 82.35% of its industry peers.
- A Quick Ratio of 0.66 indicates that LFMD may have some problems paying its short term obligations.
- LFMD has a Quick ratio of 0.66. This is amonst the worse of the industry: LFMD underperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 78.13% over the past year.
- LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.71%.
- Measured over the past years, LFMD shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
- LFMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.36% yearly.
- Based on estimates for the next years, LFMD will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y61.09%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
- Also next year LFMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, LFMD is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFMD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 682.15 | ||
| EV/EBITDA | 12.45 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LFMD's earnings are expected to grow with 34.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y34.41%
5. Dividend
5.1 Amount
- LFMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFMD.
What is the valuation status for LFMD stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 3 / 10.
How financially healthy is LIFEMD INC?
The financial health rating of LIFEMD INC (LFMD) is 4 / 10.